Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Agenus history
Agenus company history timeline
Agenus (formerly Antigenics Inc.) was founded in 1994 by Garo H. Armen and Pramod K. Srivastava.
Antigenics became a public company in February 2000 on the NASDAQ exchange with the ticker symbol AGEN. In 2000 Agenus acquired Aquila Biopharmaceuticals and a year later it acquired Aronex Pharmaceuticals.
In February 2014 the company acquired a European firm, 4-Antibody, along with their portfolio of checkpoint modulators (CPMs) and a platform (Retrocyte Display® technology) to rapidly and efficiently discover new antibodies.
In April 2014, Agenus inked a deal with Merck potentially worth $100 million.
AGEN1777 – Phase 1 target 2021: a first-in-class TIGIT bispecific to target a major inhibitory receptor expressed on T and NK cells – to improve anti-tumor activity
Rate how well Agenus lives up to its initial vision.
Agenus jobs
Do you work at Agenus?
Does Agenus communicate its history to new hires?
Agenus competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Regeneron | 1988 | $14.2B | 9,123 | 415 |
| Acorda Therapeutics | 1995 | $117.6M | 344 | - |
| Human Genome Sciences | 1992 | $131.0M | 1,000 | - |
| Gilead Sciences | 1987 | $28.8B | 11,800 | 642 |
| GlobeImmune | 1995 | $6.5M | 22 | - |
| Merck | 1891 | $64.2B | 74,000 | 2,163 |
| Titan Pharmaceuticals | 1992 | $557,000 | 23 | - |
| Forest Laboratories | 1954 | $3.6B | 6,200 | - |
| MacroGenics | 2000 | $150.0M | 307 | 13 |
| Acceleron Pharma | 2003 | $92.5M | 312 | - |
Agenus history FAQs
Zippia gives an in-depth look into the details of Agenus, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Agenus. The employee data is based on information from people who have self-reported their past or current employments at Agenus. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Agenus. The data presented on this page does not represent the view of Agenus and its employees or that of Zippia.
Agenus may also be known as or be related to AGENUS INC, Agenus, Agenus Inc and Agenus Inc.